Year: 2020

news_6

Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers

STRASBOURG, France & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--#TG4050--Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops...

news_6

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – TEVA